Cleared Traditional

K860356 - ORTHOBLEND POWERED BONE MILL

K860356 is an FDA 510(k) clearance for ORTHOBLEND POWERED BONE MILL, manufactured by Zimmer, Inc.. The device is a Class 1 Orthopedic device with product code LYS cleared through the Traditional 510(k) pathway after a 159-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 1986
Decision
159d
Days
Class 1
Risk

K860356 is an FDA 510(k) clearance for the ORTHOBLEND POWERED BONE MILL. Classified as Bone Mill (product code LYS), Class I - General Controls.

Submitted by Zimmer, Inc. (Warsaw, US). The FDA issued a Cleared decision on July 8, 1986 after a review of 159 days - an extended review cycle.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.4540 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Orthopedic review framework, consistent with the majority of Class II 510(k) submissions.

View all Zimmer, Inc. devices

FDA 510(k) Submission Details - K860356

510(k) Number K860356 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 30, 1986
Decision Date July 08, 1986
Days to Decision 159 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
37d slower than avg
Panel avg: 122d · This submission: 159d
Pathway characteristics
Predicate-based equivalence.

LYS Device Classification - Class 1, General Controls

Product Code LYS Bone Mill
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 888.4540
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.